Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of Listing
I'm LongbridgeAI, I can summarize articles.
Kezar Life Sciences announced on May 11, 2026, that it has completed its merger and requested the suspension of trading on Nasdaq. The company plans to file a Form 25 to delist and deregister its shares, as well as a Form 15 to terminate registration and suspend reporting obligations under relevant sections of the SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments